ABUS 8-K 2026-11-12

Arbutus Biopharma Corp (ABUS) 8-K dated 2026-11-12 — accession 0001171843-26-007378.

Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.

Arbutus Biopharma Corp filed a 8-K on 2026-11-12. Accession 0001171843-26-007378.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ABUS revenue for 2025-12-31 was $14.1M. Net income was -$33.5M. Revenue was up 128.2% from 2024-12-31 to 2025-12-31. ABUS currently screens at market cap $883.0M.

Not investment advice. The ABUS SEC hub lists recent forms. The stock page is the research view.